Clinical Trials Browser

NETWORK × Androgen Antagonists × Clear all

NCT03419234 2026-03-12

Abiraterone Acetate and Antiandrogen Therapy With or Without Cabazitaxel and Prednisone in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer Previously Treated With Docetaxel

Phase 2 Active not recruiting

223 enrolled 14 charts

Prostatic Neoplasms

NCT01546987 2026-03-06

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Phase 3 Completed

239 enrolled 38 charts

Prostatic Neoplasms

NCT06235697 2026-01-13

ASCENDE-SBRT

Phase 3 Recruiting

Prostatic Neoplasms

NCT00309985 2025-12-11

CHAARTED

Phase 3 Completed

790 enrolled 11 charts

Metastatic Hormone-sensitive Prostate Cancer

NCT00288080 2022-06-21

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Phase 3 Completed

612 enrolled 11 charts

Prostatic Neoplasms

NCT00949962 2014-07-04

Post-operative or Early Salvage XRT and ADT for High Risk PCa

Phase 3 Terminated

Prostatic Neoplasms